The present invention concerns methods and means to produce humanized
antibodies from transgenic non-human animals. The invention specifically
relates to novel immunoglobulin heavy and light chain constructs,
recombination and transgenic vectors useful in making transgenic
non-human animals expressing humanized antibodies, transgenic animals,
and humanized immunoglobulin preparations.